Oxford University will be launching a £10m research programme into the effects of medical marijuana, following calls for its legalization.
The program will analyze the function of cannabis medications in treating pain, cancer and inflammatory diseases.
It follows calls from some MPs for legalization of cannabis on medical reasons, with such calls being backed by 58 per cent this past year.
In the last few years, studies have supported the medical value of cannabis for treating ailments for example multiple sclerosis, epilepsy and arthritis, and for coping with nerve pain.
The new program is a partnership between Kingsley Capital Partners and Oxford University, who are investing £10m an attempt to create an international center of excellence in cannabinoid research.